Anfield Capital Management’s First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF HYLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21K Buy
+517
New +$21.4K 0.01% 339
2021
Q3
Sell
-938
Closed -$46K 195
2021
Q2
$46K Buy
+938
New +$45.6K 0.02% 120
2020
Q1
Sell
-938
Closed -$46K 229
2019
Q4
$46K Buy
+938
New +$45.3K 0.02% 214

Other funds holding HYLS

Anfield Capital Management's HYLS Position: Q1 2026 in Review

Anfield Capital Management opened a new position in First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF (HYLS) in Q1 2026: 517 shares worth $21K. The stake represents 0.01% of the portfolio and ranks #339 among its holdings. This is a return to the name: Anfield Capital Management previously reported a position in HYLS as recently as Q2 2021.

Anfield Capital Management first reported a position in HYLS in Q4 2019 and has held it in 3 quarters since. The position peaked at $46K in Q2 2021. 221 funds tracked by Wall St. Rank hold HYLS as of Q1 2026.

  • Anfield Capital Management held 517 shares of First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF worth $21K as of Q1 2026.
  • First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF was a new Anfield Capital Management position in Q1 2026.
  • First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF made up 0.01% of Anfield Capital Management's portfolio in Q1 2026, its #339 holding.
  • Anfield Capital Management first reported a position in First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2019 and has held it in 3 quarters since.
  • Anfield Capital Management's First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF position peaked at $46K in Q2 2021.
  • 221 funds tracked by Wall St. Rank held First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.